{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T17:09:25Z","timestamp":1791220165426,"version":"4.1.0"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,6,23]],"date-time":"2020-06-23T00:00:00Z","timestamp":1592870400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,6,23]],"date-time":"2020-06-23T00:00:00Z","timestamp":1592870400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100019018","name":"Chinese Academy of Medical Sciences Initiative for Innovative Medicine","doi-asserted-by":"crossref","award":["CAMS-2017-I2M-1-002"],"award-info":[{"award-number":["CAMS-2017-I2M-1-002"]}],"id":[{"id":"10.13039\/501100019018","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100019018","name":"Chinese Academy of Medical Sciences Initiative for Innovative Medicine","doi-asserted-by":"crossref","award":["CAMS-2017-I2M-1-002"],"award-info":[{"award-number":["CAMS-2017-I2M-1-002"]}],"id":[{"id":"10.13039\/501100019018","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Epigenet"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Despite rapid improvements in DNA methylation tools for cervical cancer screening, few robust, exploratory studies have been performed using the combination of two host genes, <jats:italic>EPB41L3<\/jats:italic> and <jats:italic>JAM3<\/jats:italic>, newly developed assays.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>A review of abnormal liquid-based cytology and\/or high-risk human papillomavirus (hrHPV) data from outpatient clinics in the study center from March 2018 to March 2019 was performed. Eligible patients with definitive histological pathology results were included, and their residual cytology samples were assessed for <jats:italic>EPB41L3<\/jats:italic> and <jats:italic>JAM3<\/jats:italic> methylation. The diagnostic accuracies of various screening strategies for definitive pathology and for cervical intraepithelial neoplasia (CIN) 2 or more severe lesions (CIN2+) were compared.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>In total, 306 patients were successfully tested; 301 cases with cervical histological pathology were included in the final analysis, including 118 (39.2%) and 183 (60.8%) cases of inflammation\/CIN1 and CIN2+, respectively. Regarding CIN2+ detection, methylation status and hrHPV plus methylation had similar positive predictive values (0.930 and 0.954, respectively, <jats:italic>p<\/jats:italic> = 0.395). Additionally, hrHPV, methylation, and hrHPV plus methylation had similar negative predictive values (0.612, 0.679, and 0.655, <jats:italic>p<\/jats:italic> = 0.677) that were significantly higher than that of cytology alone (0.250, <jats:italic>p<\/jats:italic> values 0.012, 0.001, and 0.001, respectively). For 49 cases with negative hrHPV results, positive methylation alone was able to differentiate CIN2+ from inflammation\/CIN1.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Methylation of both <jats:italic>EPB41L3<\/jats:italic> and <jats:italic>JAM3<\/jats:italic> is an accurate and feasible screening method for CIN2+.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13148-020-00885-7","type":"journal-article","created":{"date-parts":[[2020,6,23]],"date-time":"2020-06-23T11:03:07Z","timestamp":1592910187000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":43,"title":["DNA methylation for cervical cancer screening: a training set in China"],"prefix":"10.1186","volume":"12","author":[{"given":"Linghua","family":"Kong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linhai","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziyun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoping","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"You","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huanwen","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8723-3461","authenticated-orcid":false,"given":"Lei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,6,23]]},"reference":[{"key":"885_CR1","doi-asserted-by":"crossref","unstructured":"Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018:68(6).","DOI":"10.3322\/caac.21492"},{"issue":"2","key":"885_CR2","doi-asserted-by":"publisher","first-page":"115","DOI":"10.3322\/caac.21338","volume":"66","author":"W Chen","year":"2016","unstructured":"Chen W, Zheng R, Baade PD, Zhang S, Zeng H, Bray F, et al. Cancer statistics in China, 2015. CA Cancer J Clin. 2016;66(2):115.","journal-title":"CA Cancer J Clin"},{"issue":"2","key":"885_CR3","doi-asserted-by":"publisher","first-page":"295","DOI":"10.21147\/j.issn.1000-9604.2019.02.04","volume":"31","author":"National Health Commission Of The People's Republic Of China","year":"2019","unstructured":"National Health Commission Of The People's Republic Of China. Chinese guidelines for diagnosis and treatment of cervical cancer 2018 (English version). Chin J Cancer Res. 2019;31(2):295.","journal-title":"Chin J Cancer Res"},{"issue":"4","key":"885_CR4","doi-asserted-by":"crossref","first-page":"271","DOI":"10.3322\/caac.21349","volume":"66","author":"KD Miller","year":"2016","unstructured":"Miller KD, Siegel RL, Lin CC, Mariotto AB, Kramer JL, Rowland JH, et al. Cancer treatment and survivorship statistics, 2016. CA Cancer J Clin. 2016;66(4):271.","journal-title":"CA Cancer J Clin"},{"issue":"3","key":"885_CR5","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1097\/LGT.0b013e31824ca9d5","volume":"16","author":"D Saslow","year":"2012","unstructured":"Saslow D, Solomon D, Lawson HW, Killackey M, Kulasingam SL, Cain JM, et al. American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer. J Low Genit Tract Dis. 2012;16(3):147.","journal-title":"J Low Genit Tract Dis"},{"issue":"5 Suppl 1","key":"885_CR6","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1097\/LGT.0b013e318287d329","volume":"17","author":"LS Massad","year":"2013","unstructured":"Massad LS, Einstein MH, Huh WK, Katki HA, Kinney WK, Schiffman M, et al. 2012 updated consensus guidelines for the management of abnormal cervical cancer screening tests and cancer precursors. J Low Genit Tract Dis. 2013;17(5 Suppl 1):S1\u20132.","journal-title":"J Low Genit Tract Dis"},{"issue":"4","key":"885_CR7","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1002\/ijc.31897","volume":"144","author":"RW van Leeuwen","year":"2019","unstructured":"van Leeuwen RW, Ostrbenk A, Poljak M, van der Zee AGJ, Schuuring E, Wisman GBA. DNA methylation markers as a triage test for identification of cervical lesions in a high risk human papillomavirus positive screening cohort. Int J Cancer. 2019;144(4):746.","journal-title":"Int J Cancer"},{"issue":"10","key":"885_CR8","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1080\/14737140.2016.1232166","volume":"16","author":"RM Ebisch","year":"2016","unstructured":"Ebisch RM, Siebers AG, Bosgraaf RP, Massuger LF, Bekkers RL, Melchers WJ. Triage of high-risk HPV positive women in cervical cancer screening. Expert Rev Anticancer Ther. 2016;16(10):1073.","journal-title":"Expert Rev Anticancer Ther"},{"issue":"4","key":"885_CR9","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1002\/ijc.31261","volume":"143","author":"K Cuschieri","year":"2018","unstructured":"Cuschieri K, Ronco G, Lorincz A, Smith L, Ogilvie G, Mirabello L, et al. Eurogin roadmap 2017: triage strategies for the management of HPV-positive women in cervical screening programs. Int J Cancer. 2018;143(4):735.","journal-title":"Int J Cancer"},{"issue":"1","key":"885_CR10","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/1868-7083-4-13","volume":"4","author":"KP Saavedra","year":"2012","unstructured":"Saavedra KP, Brebi PM, Roa JC. Epigenetic alterations in preneoplastic and neoplastic lesions of the cervix. Clin Epigenetics. 2012;4(1):13.","journal-title":"Clin Epigenetics"},{"issue":"6990","key":"885_CR11","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1038\/nature02625","volume":"429","author":"G Egger","year":"2004","unstructured":"Egger G, Liang G, Aparicio A, Jones PA. Epigenetics in human disease and prospects for epigenetic therapy. Nature. 2004;429(6990):457.","journal-title":"Nature"},{"issue":"6","key":"885_CR12","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1038\/nrg816","volume":"3","author":"PA Jones","year":"2002","unstructured":"Jones PA, Baylin SB. The fundamental role of epigenetic events in cancer. Nat Rev Genet. 2002;3(6):415.","journal-title":"Nat Rev Genet"},{"issue":"6","key":"885_CR13","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1159\/000450595","volume":"60","author":"AT Lorincz","year":"2016","unstructured":"Lorincz AT. Virtues and weaknesses of DNA methylation as a test for cervical cancer prevention. Acta Cytol. 2016;60(6):501.","journal-title":"Acta Cytol"},{"issue":"3","key":"885_CR14","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1586\/14737159.2014.897610","volume":"14","author":"AT Lorincz","year":"2014","unstructured":"Lorincz AT. Cancer diagnostic classifiers based on quantitative DNA methylation. Expert Rev Mol Diagn. 2014;14(3):293.","journal-title":"Expert Rev Mol Diagn"},{"issue":"11","key":"885_CR15","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1038\/s41416-019-0593-4","volume":"121","author":"H Kelly","year":"2019","unstructured":"Kelly H, Benavente Y, Pavon MA, De Sanjose S, Mayaud P, Lorincz AT. Performance of DNA methylation assays for detection of high-grade cervical intraepithelial neoplasia (CIN2+): a systematic review and meta-analysis. Br J Cancer. 2019;121(11):954.","journal-title":"Br J Cancer"},{"issue":"1","key":"885_CR16","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1186\/s13148-019-0743-9","volume":"11","author":"R Hernandez-Lopez","year":"2019","unstructured":"Hernandez-Lopez R, Lorincz AT, Torres-Ibarra L, Reuter C, Scibior-Bentkowska D, Warman R, et al. Methylation estimates the risk of precancer in HPV-infected women with discrepant results between cytology and HPV16\/18 genotyping. Clin Epigenetics. 2019;11(1):140.","journal-title":"Clin Epigenetics"},{"issue":"3","key":"885_CR17","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1016\/j.ygyno.2018.06.014","volume":"150","author":"CD Rogeri","year":"2018","unstructured":"Rogeri CD, Silveira HCS, Causin RL, Villa LL, Stein MD, de Carvalho AC, et al. Methylation of the hsa-miR-124, SOX1, TERT, and LMX1A genes as biomarkers for precursor lesions in cervical cancer. Gynecol Oncol. 2018;150(3):545.","journal-title":"Gynecol Oncol"},{"issue":"15","key":"885_CR18","doi-asserted-by":"publisher","first-page":"2227","DOI":"10.1097\/QAD.0000000000001932","volume":"32","author":"HA Kelly","year":"2018","unstructured":"Kelly HA, Chikandiwa A, Warman R, Segondy M, Sawadogo B, Vasiljevic N, et al. Associations of human gene EPB41L3 DNA methylation and cervical intraepithelial neoplasia in women living with HIV-1 in Africa. AIDS. 2018;32(15):2227.","journal-title":"AIDS"},{"issue":"4","key":"885_CR19","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1002\/ijc.30781","volume":"141","author":"MA Clarke","year":"2017","unstructured":"Clarke MA, Luhn P, Gage JC, Bodelon C, Dunn ST, Walker J, et al. Discovery and validation of candidate host DNA methylation markers for detection of cervical precancer and cancer. Int J Cancer. 2017;141(4):701.","journal-title":"Int J Cancer"},{"issue":"11","key":"885_CR20","doi-asserted-by":"publisher","first-page":"2745","DOI":"10.1002\/ijc.30008","volume":"138","author":"AT Lorincz","year":"2016","unstructured":"Lorincz AT, Brentnall AR, Scibior-Bentkowska D, Reuter C, Banwait R, Cadman L, et al. Validation of a DNA methylation HPV triage classifier in a screening sample. Int J Cancer. 2016;138(11):2745.","journal-title":"Int J Cancer"},{"issue":"6","key":"885_CR21","doi-asserted-by":"publisher","first-page":"E638","DOI":"10.1002\/ijc.29196","volume":"136","author":"K Louvanto","year":"2015","unstructured":"Louvanto K, Franco EL, Ramanakumar AV, Vasiljevic N, Scibior-Bentkowska D, Koushik A, et al. Methylation of viral and host genes and severity of cervical lesions associated with human papillomavirus type 16. Int J Cancer. 2015;136(6):E638.","journal-title":"Int J Cancer"},{"issue":"5","key":"885_CR22","doi-asserted-by":"publisher","first-page":"669","DOI":"10.3233\/CBM-150507","volume":"15","author":"AR Brentnall","year":"2015","unstructured":"Brentnall AR, Vasiljevic N, Scibior-Bentkowska D, Cadman L, Austin J, Cuzick J, et al. HPV33 DNA methylation measurement improves cervical pre-cancer risk estimation of an HPV16, HPV18, HPV31 and \\textit{EPB41L3} methylation classifier. Cancer Biomark. 2015;15(5):669.","journal-title":"Cancer Biomark"},{"issue":"9","key":"885_CR23","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1111\/pin.12332","volume":"65","author":"I Blanco-Luquin","year":"2015","unstructured":"Blanco-Luquin I, Guarch R, Ojer A, Perez-Janices N, Martin-Sanchez E, Maria-Ruiz S, et al. Pathol Int. 2015;65(9):476.","journal-title":"Pathol Int"},{"issue":"6","key":"885_CR24","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1002\/ijc.28790","volume":"135","author":"AR Brentnall","year":"2014","unstructured":"Brentnall AR, Vasiljevic N, Scibior-Bentkowska D, Cadman L, Austin J, Szarewski A, et al. A DNA methylation classifier of cervical precancer based on human papillomavirus and human genes. Int J Cancer. 2014;135(6):1425.","journal-title":"Int J Cancer"},{"issue":"3","key":"885_CR25","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1007\/s00404-018-4796-3","volume":"298","author":"Z Guo","year":"2018","unstructured":"Guo Z, Hu Y, Yuan L, Li N, Wang T. A prospective study on the predictive value of DNA methylation in cervical intraepithelial neoplasia prognosis. Arch Gynecol Obstet. 2018;298(3):589.","journal-title":"Arch Gynecol Obstet"},{"issue":"42","key":"885_CR26","doi-asserted-by":"publisher","first-page":"44373","DOI":"10.18632\/oncotarget.6250","volume":"6","author":"A Yin","year":"2015","unstructured":"Yin A, Zhang Q, Kong X, Jia L, Yang Z, Meng L, et al. JAM3 methylation status as a biomarker for diagnosis of preneoplastic and neoplastic lesions of the cervix. Oncotarget. 2015;6(42):44373.","journal-title":"Oncotarget"},{"key":"885_CR27","doi-asserted-by":"crossref","unstructured":"Boers A, Bosgraaf RP, van Leeuwen RW, Schuuring E, Heideman DA, Massuger LF, et al. DNA methylation analysis in self-sampled brush material as a triage test in hrHPV-positive women. Br J Cancer. 2014;(6):111, 1095.","DOI":"10.1038\/bjc.2014.392"},{"key":"885_CR28","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1186\/s13148-016-0196-3","volume":"8","author":"A Boers","year":"2016","unstructured":"Boers A, Wang R, van Leeuwen RW, Klip HG, de Bock GH, Hollema H, et al. Discovery of new methylation markers to improve screening for cervical intraepithelial neoplasia grade 2\/3. Clin Epigenetics. 2016;8:829.","journal-title":"Clin Epigenetics"},{"issue":"8","key":"885_CR29","doi-asserted-by":"publisher","first-page":"1861","DOI":"10.1002\/ijc.26326","volume":"130","author":"JJ Eijsink","year":"2012","unstructured":"Eijsink JJ, Lendvai A, Deregowski V, Klip HG, Verpooten G, Dehaspe L, et al. A four-gene methylation marker panel as triage test in high-risk human papillomavirus positive patients. Int J Cancer. 2012;130(8):1861.","journal-title":"Int J Cancer"},{"issue":"2","key":"885_CR30","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.ygyno.2010.10.029","volume":"120","author":"JJ Eijsink","year":"2011","unstructured":"Eijsink JJ, Yang N, Lendvai A, Klip HG, Volders HH, Buikema HJ, et al. Detection of cervical neoplasia by DNA methylation analysis in cervico-vaginal lavages, a feasibility study. Gynecol Oncol. 2011;120(2):280.","journal-title":"Gynecol Oncol"},{"issue":"3","key":"885_CR31","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/j.ygyno.2014.02.001","volume":"132","author":"N Vasiljevic","year":"2014","unstructured":"Vasiljevic N, Scibior-Bentkowska D, Brentnall AR, Cuzick J, Lorincz AT. Credentialing of DNA methylation assays for human genes as diagnostic biomarkers of cervical intraepithelial neoplasia in high-risk HPV positive women. Gynecol Oncol. 2014;132(3):709.","journal-title":"Gynecol Oncol"},{"issue":"2","key":"885_CR32","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1097\/PAS.0000000000000986","volume":"42","author":"S Stolnicu","year":"2018","unstructured":"Stolnicu S, Barsan I, Hoang L, Patel P, Terinte C, Pesci A, et al. International Endocervical adenocarcinoma criteria and classification (IECC): a new pathogenetic classification for invasive adenocarcinomas of the endocervix. Am J Surg Pathol. 2018;42(2):214.","journal-title":"Am J Surg Pathol"},{"issue":"5","key":"885_CR33","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1002\/cncy.21521","volume":"123","author":"R Nayar","year":"2015","unstructured":"Nayar R, Wilbur DC. The pap test and Bethesda 2014. Cancer Cytopathol. 2015;123(5):271.","journal-title":"Cancer Cytopathol"},{"key":"885_CR34","doi-asserted-by":"crossref","unstructured":"Cook DA, Krajden M, Brentnall AR, Gondara L, Chan T, Law JH, et al. Evaluation of a validated methylation triage signature for human papillomavirus positive women in the HPV FOCAL cervical cancer screening trial. Int J Cancer. 2018.","DOI":"10.1002\/ijc.31976"},{"issue":"1","key":"885_CR35","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1002\/cncr.23258","volume":"114","author":"SL Kahn","year":"2008","unstructured":"Kahn SL, Ronnett BM, Gravitt PE, Gustafson KS. Quantitative methylation-specific PCR for the detection of aberrant DNA methylation in liquid-based pap tests. Cancer. 2008;114(1):57.","journal-title":"Cancer"},{"issue":"1","key":"885_CR36","doi-asserted-by":"publisher","first-page":"e0210289","DOI":"10.1371\/journal.pone.0210289","volume":"14","author":"W Dankai","year":"2019","unstructured":"Dankai W, Khunamornpong S, Siriaunkgul S, Soongkhaw A, Janpanao A, Utaipat U, et al. Role of genomic DNA methylation in detection of cytologic and histologic abnormalities in high risk HPV-infected women. PLoS One. 2019;14(1):e0210289.","journal-title":"PLoS One"},{"issue":"8","key":"885_CR37","doi-asserted-by":"publisher","first-page":"939","DOI":"10.4103\/0366-6999.229896","volume":"131","author":"LL Sun","year":"2018","unstructured":"Sun LL, Liu Y, Sun X, Pan L, Wu D, Wang YD. Limited role of promoter methylation of MGMT and C13ORF18 in triage of low-grade squamous intraepithelial lesion. Chin Med J. 2018;131(8):939.","journal-title":"Chin Med J"},{"key":"885_CR38","doi-asserted-by":"crossref","unstructured":"Qin R, Cao L, Wang J, Liu J. Promoter methylation of ezrin and its impact on the incidence and prognosis of cervical cancer. Cell Physiol Biochem. 2018, 50(1):277.","DOI":"10.1159\/000494005"},{"issue":"1","key":"885_CR39","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1186\/s12885-018-4877-5","volume":"18","author":"Q Bu","year":"2018","unstructured":"Bu Q, Wang S, Ma J, Zhou X, Hu G, Deng H, et al. The clinical significance of FAM19A4 methylation in high-risk HPV-positive cervical samples for the detection of cervical (pre)cancer in Chinese women. BMC Cancer. 2018;18(1):1182.","journal-title":"BMC Cancer"},{"issue":"8","key":"885_CR40","doi-asserted-by":"publisher","first-page":"1908","DOI":"10.1002\/ijc.22060","volume":"119","author":"GB Wisman","year":"2006","unstructured":"Wisman GB, Nijhuis ER, Hoque MO, Reesink-Peters N, Koning AJ, Volders HH, et al. Assessment of gene promoter hypermethylation for detection of cervical neoplasia. Int J Cancer. 2006;119(8):1908.","journal-title":"Int J Cancer"},{"key":"885_CR41","doi-asserted-by":"publisher","unstructured":"Lin CJ, Lai HC, Wang KH, Hsiung CA, Liu HW, Ding DC, et al. Testing for methylated PCDH10 or WT1 is superior to the HPV test in detecting severe neoplasms (CIN3 or greater) in the triage of ASC-US smear results. Am J Obstet Gynecol. 2011;204(1). https:\/\/doi.org\/10.1016\/j.ajog.2010.07.036.","DOI":"10.1016\/j.ajog.2010.07.036"},{"issue":"1","key":"885_CR42","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1002\/dc.21758","volume":"41","author":"TK Chao","year":"2013","unstructured":"Chao TK, Ke FY, Liao YP, Wang HC, Yu CP, Lai HC. Triage of cervical cytological diagnoses of atypical squamous cells by DNA methylation of paired boxed gene 1 (PAX1). Diagn Cytopathol. 2013;41(1):41.","journal-title":"Diagn Cytopathol"},{"key":"885_CR43","doi-asserted-by":"publisher","first-page":"258","DOI":"10.3389\/fgene.2018.00258","volume":"9","author":"XB Wang","year":"2018","unstructured":"Wang XB, Cui NH, Liu XN, Ma JF, Zhu QH, Guo SR, et al. Identification of DAPK1 promoter hypermethylation as a biomarker for intra-epithelial lesion and cervical cancer: a meta-analysis of published studies, TCGA, and GEO datasets. Front Genet. 2018;9:258.","journal-title":"Front Genet"},{"key":"885_CR44","volume-title":"Molecular progression to cervical precancer, epigenetic switch or sequential model? Int J cancer","author":"B Nedjai","year":"2018","unstructured":"Nedjai B, Reuter C, Ahmad A, Banwait R, Warman R, Carton J, et al. Molecular progression to cervical precancer, epigenetic switch or sequential model? Int J cancer; 2018."},{"issue":"10167","key":"885_CR45","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/S0140-6736(18)32470-X","volume":"393","author":"PA Cohen","year":"2019","unstructured":"Cohen PA, Jhingran A, Oaknin A, Denny L. Cervical cancer. Lancet. 2019;393(10167):169.","journal-title":"Lancet"},{"issue":"6","key":"885_CR46","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1038\/ncponc0822","volume":"4","author":"ME Beiner","year":"2007","unstructured":"Beiner ME, Covens A. Surgery insight: radical vaginal trachelectomy as a method of fertility preservation for cervical cancer. Nat Clin Pract Oncol. 2007;4(6):353.","journal-title":"Nat Clin Pract Oncol"},{"issue":"4","key":"885_CR47","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1016\/S0002-9440(10)64619-6","volume":"157","author":"EC Pirog","year":"2000","unstructured":"Pirog EC, Kleter B, Olgac S, Bobkiewicz P, Lindeman J, Quint WG, et al. Prevalence of human papillomavirus DNA in different histological subtypes of cervical adenocarcinoma. Am J Pathol. 2000;157(4):1055.","journal-title":"Am J Pathol"},{"issue":"12","key":"885_CR48","doi-asserted-by":"publisher","first-page":"1559","DOI":"10.1038\/modpathol.2014.55","volume":"27","author":"EC Pirog","year":"2014","unstructured":"Pirog EC, Lloveras B, Molijn A, Tous S, Guimera N, Alejo M, et al. HPV prevalence and genotypes in different histological subtypes of cervical adenocarcinoma, a worldwide analysis of 760 cases. Mod Pathol. 2014;27(12):1559.","journal-title":"Mod Pathol"},{"issue":"12","key":"885_CR49","doi-asserted-by":"publisher","first-page":"2858","DOI":"10.1002\/ijc.29651","volume":"137","author":"K Holl","year":"2015","unstructured":"Holl K, Nowakowski AM, Powell N, McCluggage WG, Pirog EC, Collas De Souza S, et al. Human papillomavirus prevalence and type-distribution in cervical glandular neoplasias: results from a European multinational epidemiological study. Int J Cancer. 2015;137(12):2858.","journal-title":"Int J Cancer"},{"issue":"2","key":"885_CR50","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1002\/ijc.29722","volume":"138","author":"A Molijn","year":"2016","unstructured":"Molijn A, Jenkins D, Chen W, Zhang X, Pirog E, Enqi W, et al. The complex relationship between human papillomavirus and cervical adenocarcinoma. Int J Cancer. 2016;138(2):409.","journal-title":"Int J Cancer"},{"issue":"3","key":"885_CR51","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1016\/j.ygyno.2009.05.013","volume":"114","author":"KD Quint","year":"2009","unstructured":"Quint KD, de Koning MNC, Geraets DT, Quint WGV, Pirog EC. Comprehensive analysis of human papillomavirus and chlamydia trachomatis in in-situ and invasive cervical adenocarcinoma. Gynecol Oncol. 2009;114(3):390.","journal-title":"Gynecol Oncol"},{"issue":"12","key":"885_CR52","doi-asserted-by":"publisher","first-page":"2687","DOI":"10.1002\/ijc.30401","volume":"139","author":"W Chen","year":"2016","unstructured":"Chen W, Molijn A, Enqi W, Zhang X, Jenkins D, Yu X, et al. The variable clinicopathological categories and role of human papillomavirus in cervical adenocarcinoma: a hospital based nation-wide multi-center retrospective study across China. Int J Cancer. 2016;139(12):2687.","journal-title":"Int J Cancer"},{"issue":"12","key":"885_CR53","doi-asserted-by":"publisher","first-page":"1653","DOI":"10.5858\/arpa.2016-0356-RA","volume":"141","author":"EC Pirog","year":"2017","unstructured":"Pirog EC. Cervical adenocarcinoma: diagnosis of human papillomavirus-positive and human papillomavirus-negative tumors. Arch Pathol Lab Med. 2017;141(12):1653.","journal-title":"Arch Pathol Lab Med"},{"issue":"9","key":"885_CR54","doi-asserted-by":"publisher","first-page":"2168","DOI":"10.1002\/ijc.21609","volume":"118","author":"S Kang","year":"2006","unstructured":"Kang S, Kim JW, Kang GH, Lee S, Park NH, Song YS, et al. Comparison of DNA hypermethylation patterns in different types of uterine cancer: cervical squamous cell carcinoma, cervical adenocarcinoma and endometrial adenocarcinoma. Int J Cancer. 2006;118(9):2168.","journal-title":"Int J Cancer"},{"issue":"9","key":"885_CR55","first-page":"2168","volume":"18","author":"EJ Lee","year":"2010","unstructured":"Lee EJ, McClelland M, Wang Y, Long F, Choi SH, Lee JH, et al. Oncol Res. 2010;18(9):2168.","journal-title":"Oncol Res"},{"issue":"8","key":"885_CR56","doi-asserted-by":"publisher","first-page":"e25165","DOI":"10.1002\/jia2.25165","volume":"21","author":"WW Kremer","year":"2018","unstructured":"Kremer WW, Van Zummeren M, Novianti PW, Richter KL, Verlaat W, Snijders PJ, et al. Detection of hypermethylated genes as markers for cervical screening in women living with HIV. J Int AIDS Soc. 2018;21(8):e25165.","journal-title":"J Int AIDS Soc"},{"issue":"1","key":"885_CR57","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1002\/dc.23838","volume":"46","author":"HJ Kim","year":"2018","unstructured":"Kim HJ, Kim CY, Jin J, Bae MK, Kim YH, Ju W, et al. Aberrant single-minded homolog 1 methylation as a potential biomarker for cervical cancer. Diagn Cytopathol. 2018;46(1):15.","journal-title":"Diagn Cytopathol"},{"issue":"5","key":"885_CR58","doi-asserted-by":"publisher","first-page":"7004","DOI":"10.1002\/jcp.27453","volume":"234","author":"F Shen","year":"2019","unstructured":"Shen F, Zheng H, Zhou L, Li W, Liu J, Xu X. Identification of CD28 and PTEN as novel prognostic markers for cervical cancer. J Cell Physiol. 2019;234(5):7004.","journal-title":"J Cell Physiol"}],"container-title":["Clinical Epigenetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13148-020-00885-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13148-020-00885-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13148-020-00885-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,17]],"date-time":"2022-04-17T18:03:23Z","timestamp":1650218603000},"score":1,"resource":{"primary":{"URL":"https:\/\/clinicalepigeneticsjournal.biomedcentral.com\/articles\/10.1186\/s13148-020-00885-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,23]]},"references-count":58,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["885"],"URL":"https:\/\/doi.org\/10.1186\/s13148-020-00885-7","relation":{},"ISSN":["1868-7075","1868-7083"],"issn-type":[{"value":"1868-7075","type":"print"},{"value":"1868-7083","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,23]]},"assertion":[{"value":"20 January 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 June 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 June 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The Institutional Review Board of Peking Union Medical College Hospital approved this study (No. JS-1954). The registration number is NCT03961191 (, registered on May 23, 2019).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Consent for publication was obtained from all patients.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"All authors declare that they have no conflicts of interest to disclose.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"91"}}